Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer

NCT05253066 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Chidamide combined with exemestane (+/- goserelin)
DRUG: Chemotherapy with docetaxel plus epirubicin or change of chemotherapy regimen (at the discretion of the clinician)

Sponsor

Shengjing Hospital